MedPath

Towards Optimal Fertility, Fathering and Fatherhood studY

Recruiting
Conditions
Fertility Issues
Reproductive Issues
Interventions
Other: Lifestyle and metabolic indicators
Registration Number
NCT06293235
Lead Sponsor
KK Women's and Children's Hospital
Brief Summary

This case-control study involving fertile and subfertile couples aims to identify male factors related to pregnancy likelihood, create a fertility index measure combining male and female factors to predict pregnancy likelihood, and examine how male factors relate to the semen physical and biological characteristics.

Detailed Description

Paternal contributions to fertility and reproductive health outcomes have been understudied, despite promising evidence from animal studies. This study aims to investigate the male contribution to pregnancy likelihood and explore the underlying biological mechanisms. Specifically, the investigators aim to (1) identify male factors associated with pregnancy rate; (2) develop a fertility index combining modifiable factors for both males and females to predict pregnancy rate; and (3) explore the relationship of male modifiable factors with semen physical and molecular characteristics. This is a case-control study with 480 fertile and subfertile males (along with their female partners), recruited from KK Women's and Children's Hospital. The investigators will use questionnaires to collect data on socio-demographic characteristics, clinical, lifestyle, and environmental factors; analyze metabolic and stress biomarkers from blood samples; and measure semen parameters including sperm motility, density, morphology, volume, DNA fragmentation, DNA methylation, gene expression, and seminal plasma oxidative status. Findings from this proposed study will pave the way for developing lifestyle-based or medical interventions to enhance male and couple reproductive health, and potentially benefiting future offspring health.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
960
Inclusion Criteria

Subfertile couples:

  • men aged ≥21-49 years
  • men with a female partner aged 21-39 years
  • couples who are not able to conceive for at least 12 months
  • couples who are Singapore citizen or permanent resident

Fertile couples:

  • men aged 21-49 years
  • men with a female partner aged 21-39 years
  • men with proven fertility defined as those female partners who are currently pregnant and with viable intrauterine pregnancy at gestational weeks of less or equal to 16 at the time of the study
  • couples with attempted time to conceive within 12 months to achieve this pregnancy or with unplanned pregnancy
  • couples who are Singapore citizen or permanent resident
Exclusion Criteria

Subfertile couples:

  • male infertility of a known aetiology including azoospermia, retrograde ejaculation, genetic disorders, cancer treatment, or testes trauma
  • female infertility diagnosis as confirmed by diagnostic imaging or having severe endometriosis
  • female partners with irregular menstrual cycle >35 days
  • couples with known chromosomal abnormalities

Fertile couples:

  • couples who achieve pregnancy after oocyte or spermatozoa donation
  • couples with known chromosomal abnormalities
  • female partners with known uterine abnormalities

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Subfertile couplesLifestyle and metabolic indicatorsCouples who are not able to conceive for at least 12 months with female partners without infertility diagnosis.
Fertile couplesLifestyle and metabolic indicatorsCouples with attempted time to conceive within 12 months to achieve this pregnancy or with unplanned pregnancy, with female partners who are currently pregnant with viable intrauterine pregnancy.
Primary Outcome Measures
NameTimeMethod
Pregnancy rateUp to 16 weeks of gestation

Defined by viable intrauterine pregnancy at gestational weeks of less or equal to 16 at the time of the study

Secondary Outcome Measures
NameTimeMethod
Sperm concentrationUp to 2 years

Assessed by semen analysis in million/ml

Sperm progressive motilityUp to 2 years

Assessed by semen analysis in percent

Oxidative stressThrough study completion, an average of 3 years

Defined by oxidative status measured from blood and semen samples using the micro-NMR

mRNA levelThrough study completion, an average of 3 years

From blood and semen samples through transcriptomics analysis

Sperm total motilityUp to 2 years

Assessed by semen analysis in percent

Total progressive motile sperm countUp to 2 years

measured by multiplying the semen volume (ml) by sperm concentration (million/ml) and the percentage of progressively motile sperm

Double strand sperm DNA fragmentationUp to 2 years

Measured by the AI-powered semen analyzer

sncRNA levelThrough study completion, an average of 3 years

From blood and semen samples through transcriptomics analysis

Fertility indexThrough study completion, an average of 3 years

Defined by a composite index score derived from both male and female predictive factors

Semen volumeUp to 2 years

Assessed by semen analysis in ml

Single strand sperm DNA fragmentationUp to 2 years

Measured by the AI-powered semen analyzer

DNA methylationThrough study completion, an average of 3 years

From blood and semen samples through bisulfite sequencing

Trial Locations

Locations (1)

KK Women's and Children's Hospital

🇸🇬

Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath